Portfolio Design Labs’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Portfolio Design Labs's LLY Position: Q2 2026 in Review
Portfolio Design Labs increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $908K and bringing the position to 9,672 shares worth $11.6M. The position accounts for 1.9% of the portfolio, ranked #13.
Portfolio Design Labs first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Portfolio Design Labs held 9,672 shares of Eli Lilly worth $11.6M as of Q2 2026.
- Portfolio Design Labs bought 889 Eli Lilly shares in Q2 2026, an estimated $908K.
- Eli Lilly made up 1.9% of Portfolio Design Labs's portfolio in Q2 2026, its #13 holding.
- Portfolio Design Labs first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Portfolio Design Labs's 13F filing for Q2 2026, filed 11 Aug 2026.